RIA
ECYT

Regal Investment Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Regal Investment Advisors’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-210
Closed – – 990
2015
Q3 		$0 Hold
210
– – ﹤0.01% 1146
2015
Q2 		$1K Hold
210
– – ﹤0.01% 913
2015
Q1 		$1K Hold
210
– – ﹤0.01% 961
2014
Q4 		$1K Buy
210
+150
+250% +$914 ﹤0.01% 905
2014
Q3 		$0 Hold
60
– – ﹤0.01% 998
2014
Q2 		$0 Hold
60
– – ﹤0.01% 964
2014
Q1 		$1K Sell
60
-140
-70% -$2.03K ﹤0.01% 875
2013
Q4 		$2K Sell
200
-90
-31% -$994 ﹤0.01% 774
2013
Q3 		$4K Sell
290
-17
-6% -$269 ﹤0.01% 744
2013
Q2 		$4K Buy
+307
New +$4.14K ﹤0.01% 737

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Regal Investment Advisors's ECYT Position: Q4 2015 in Review

Regal Investment Advisors sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2015, closing a stake of 210 shares.

Regal Investment Advisors first reported a position in ECYT in Q2 2013 and held it in 10 quarters. The position peaked at $4K in Q3 2013. 102 funds tracked by Wall St. Rank hold ECYT as of Q4 2015.

  • Regal Investment Advisors reported no remaining Endocyte, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Regal Investment Advisors sold 210 Endocyte, Inc. Common Stock shares in Q4 2015.
  • Regal Investment Advisors first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 10 quarters.
  • Regal Investment Advisors's Endocyte, Inc. Common Stock position peaked at $4K in Q3 2013.
  • 102 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2015.

Based on Regal Investment Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.